Hyperlipidaemia
13
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
15%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (13)
Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogotá
Therapeutic Effects of Cinnamon-Enriched Cookies on Hypercholesterolemia and Liver Function
Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies
Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland
Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.
Nigella Sativa Supplementation in Hyperlipidemia Treatment
Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia